OPtimizing REperfusion by Primary Intra-Arterial ThRomboLysis for Medium Vessel Occlusion
A phase 3 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 530 participants.
Also called NCT07137832
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 530 participants
- Registry
-
NCT07137832
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Recruiting
Technical summary
Registry record NCT07137832. Randomized; single masking; primary purpose treatment. Start 2025-10-09 (actual); primary completion 2028-12-31 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- OPtimizing REperfusion by Primary Intra-Arterial ThRomboLysis for Medium Vessel Occlusion
- Acronym
- PEARL-MeVO
- Condition
- Acute Ischemic Stroke
- Intervention (Combination product)
- Primary intra-arterial thrombolysis
- Intervention (Other)
- Standard medical treatment
- Lead sponsor
- Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Record details
- Record id
cardio:ct-nct07137832- Content hash
b07a5bb98952d533ad11fe1597bbae9632a7bdc42c605a9036a88ac5aa1b8e28